Researchers from Sweden’s Karolinska Institute have made significant strides in the development of an AIDS vaccine, discovering an effective antibody against HIV known as BNABS (Broadly Neutralizing Antibodies). This breakthrough could potentially halt the virus’s cellular division and spread. This information was published in a medical discussion titled “Immunity,” led by researcher Richard Wat. According to the study, BNABS antibodies can block multiple pathways through which the virus expands in the body. Typically, after HIV enters the body, it destroys immune cells, leading to a loss of disease resistance.
Although BNABS can naturally form, their levels in the body are generally low, which is why researchers aim to introduce these antibodies externally. To this end, they are developing a booster vaccine that is planned to be administered every 12 weeks. If successful, this advancement could mark a historic breakthrough in HIV and AIDS treatment. Currently, around 38 million people worldwide are affected by AIDS, with thousands succumbing to the disease each year. As there is still no permanent cure for this illness, this vaccine could provide new hope for many.
The ongoing advancements in medical science appear to open new avenues of hope for both cancer and AIDS. If the BNABS-based vaccine proves effective, it could be regarded as a groundbreaking weapon against AIDS.
Original Source: https://assam.nenow.in/hiv-vaccine-breakthrough-by-swedish-researchers-using-bnabs/
Category: জীৱনশৈলী,শীর্ষ সংবাদ,স্বাস্থ্য,AIDSResearch,BNABS,HIVVaccine,MedicalBreakthrough
Tags:
Publish Date: 2025-06-10 06:30:00
